Latest Asian Markets News

iCandy Interactive’s subsidiary Lemon Sky Studios has appointed a seasoned industry leader to drive global partnerships, secured over A$1 million in recent contracts, and is exploring strategic options to unlock shareholder value.

Coast Entertainment has reported a robust half-year performance, with ticket sales and visitation hitting new highs and EBITDA significantly exceeding prior periods. The launch of King Claw and a new Olympic partnership are key drivers of momentum.

RLF AgTech has appointed Stuart Upton as CEO, marking a strategic shift towards disciplined execution and commercial scaling of its crop nutrition and carbon platforms. Former Acting Managing Director Gavin Ball returns to Executive Director to focus on international expansion.

Xamble Group Limited is set to acquire a majority stake in YouthsToday, significantly broadening its influencer marketing platform across Southeast Asia and boosting its creator base and agency partnerships.

Audalia Resources has announced a maiden Ore Reserve for its Medcalf Titanium-Vanadium-Iron Project, supported by a robust January 2026 Pre-Feasibility Study update that highlights strong economic returns and a 9-year mine life.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Nexsen Limited has reported significant progress in its rapid diagnostic technologies, including a key FDA pre-submission for its GBS rapid sensor and a solid cash reserve post-IPO to support commercialisation efforts.

Lark Distilling Co. has reported its sixth consecutive quarter of sales growth, with net sales rising 11% to $5 million in Q2 FY26, as it prepares to launch a refreshed brand portfolio domestically and internationally.

BCI Minerals has reported solid progress on its Mardie Salt Operation and Potash Project, reaching 77% construction completion and hitting critical operational targets including pond brine density and commissioning of trial crystallisers. The company also strengthened its financial position through debt facility draws and convertible note conversions.

Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.